New York, NY · Founded 2021 · Privately Held (backing)
Developer of a brain-computer interface device technology designed to provide effective treatment for patients with neurological illnesses. Precision Neuroscience is based in New York, NY and was founded in 2021. It was valued at $529 million at its later-stage round in Oct 2024, the last priced event on record. It has raised $179 million across 4 recorded rounds; the latest was a $93.1 million later-stage round in Oct 2024.
PMV mark · valuation
$529.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$179.1M
Last round
Later Stage VC
Oct 2024
Cap table — not yet on record
Precision Neuroscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Precision Neuroscience with a free account
·The complete investor list: 17 names
·Watch Precision Neuroscience: the Monday email on marks, rounds and moves
Where does Precision Neuroscience's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Precision Neuroscience's 4 recorded funding rounds.
